A Study To Investigate The Ability To Use 18FDG PET Scanning To Monitor The Effectiveness Of New Drugs In COPD Patients
Stopped Study terminated on Nov 7, 2008 as a result of poor recruitment and changes in business priorities. The decision was not based on safety concerns.
Conditions
- Pulmonary Disease, Chronic Obstructive
Interventions
Sponsor
Pfizer
Collaborators